Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma
NCT ID: NCT02474550
Last Updated: 2017-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2015-04-30
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pre-phase Treatment Before R-CHOP Chemotherapy in Elderly Patients With Newly Diagnosed DLBCL
NCT03465527
Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL)
NCT01054781
Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)
NCT03104478
Genomic Evaluation in Patients With Diffuse Large B Cell Lymphoma After First Relapse/Progression
NCT03977623
Early Treatment Stratification Based on PET Scan Response to Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
NCT01361191
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Prphylactic peg-filgrastim on the day after chemotherapy
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CISL 14-03
* Patients who were newly diagnosed with Diffuse Large B cell Lymphoma (DLBCL).
* Aged 19 or more
* Treated with R-CHOP therapy
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* newly diagnosed with DLBCL
* R-CHOP chemotherapy
* offer informed consent
Exclusion Criteria
* concomitant other cancer
* previous chemotherapy or radiotherapy
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ajou University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seong Hyun Jeong
Associate
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seong Hyun Jeong, M.D
Role: PRINCIPAL_INVESTIGATOR
Ajou University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ajou Universtiy School of Medicine
Suwon, Kyeonggi, South Korea
Soon Chun Yang University Hospital Bucheon
Bucheon-si, , South Korea
Busan Paik Hospital
Busan, , South Korea
Chungbuk National University Hospital
Cheongju-si, , South Korea
Keimyung Univerisity Dongsan Medical Center
Daegu, , South Korea
Yeungnam University Hospital
Daegu, , South Korea
Chungnam National University Hospital
Daejeon, , South Korea
Inje University Ilsan Paik Hospital
Ilsan, , South Korea
Gachon University Gill Hospital
Incheon, , South Korea
Chonbuk Nationa University Hospital
Jeonju, , South Korea
Gyeongsang National University Hospital
Jinju, , South Korea
Asan Medical Center
Seoul, , South Korea
Choong Ang University Hopspital
Seoul, , South Korea
Hallym University Sacred Heart Hospital
Seoul, , South Korea
Hanyang University Hospital
Seoul, , South Korea
Hanyang University Medical Center
Seoul, , South Korea
Inje University Sanggye Paik Hospital
Seoul, , South Korea
Korea Cancer Center Hospital
Seoul, , South Korea
Korea Institute of Radiological & Medical Science
Seoul, , South Korea
Korea University Anam Hospital
Seoul, , South Korea
Samsung Medical Center
Seoul, , South Korea
Seoul National University Hospital
Seoul, , South Korea
Ulsan University Hospital
Ulsan, , South Korea
Wonju Severance Christian Hospital
Wŏnju, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Won Sik Lee
Role: primary
Hyejin Kang
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AJIRB-MED-OBS-14-254
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.